Lung Cancers Unknown Status Phase 2 Trials for Cisplatin (DB00515)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00792701S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung CancerTreatment
NCT00620269Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC IIITreatment
NCT00616785Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTreatment
NCT00452881Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLCTreatment
NCT00514293Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00398385Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerTreatment
NCT01623102Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung CancerTreatment
NCT00083083Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung CancerDiagnostic
NCT00005825Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00006116Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00003583Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung CancerSupportive Care